Nuzenio

Stock Titan Tourette

Stock Titan Tourette entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 12 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Axsome Reports 126% More AUVELITY Starts Among 65+ Patients in 8 Weeks - Stock TitanStock Titan · Mon, 10 Aug 2026 11:06:21 GMT Relmada Therapeutics (Nasdaq: RLMD) details Q2 2026 loss and NDV-01 Phase 3 path - Stock TitanStock Titan · Thu, 06 Aug 2026 20:41:35 GMT Royalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock TitanStock Titan · Wed, 05 Aug 2026 13:03:06 GMT SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMT Tourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMT Royalty Pharma raises 2026 receipts outlook to $3.4B-$3.5B - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMT Evogene (Nasdaq: EVGN) faces proxy slate battle and reverse split decision - Stock TitanStock Titan · Fri, 31 Jul 2026 20:02:13 GMT NeuroThera's quantum platform takes clinical data to interpretable insights in simulation - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 11:06:21 GMTAxsome Reports 126% More AUVELITY Starts Among 65+ Patients in 8 Weeks - Stock Titan

Thu, 06 Aug 2026 20:41:35 GMTRelmada Therapeutics (Nasdaq: RLMD) details Q2 2026 loss and NDV-01 Phase 3 path - Stock Titan

Wed, 05 Aug 2026 13:03:06 GMTRoyalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock Titan

Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan

Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

Wed, 05 Aug 2026 11:00:00 GMTRoyalty Pharma raises 2026 receipts outlook to $3.4B-$3.5B - Stock Titan

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Nasdaq12 live mentions Stock Titan Stock9 live mentions Titan9 live mentions SPRC6 live mentions SciSparc5 live mentions Tourette3 live mentions Stock Titan SciSparc3 live mentions More AUVELITY Starts2 live mentions Among2 live mentions Patients2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Tourette.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.